Global, regional, and national burden of intestinal obstruction from 1990 to 2019: an analysis from the Global Burden of Disease Study 2019

Long, Dan; Mao, Chenhan; Liu, Yaxuan; Zhou, Tao; Xu, Yin; Zhu, Ying

doi:10.1007/s00384-023-04522-6

Cited by 4 publications

(2 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The Global Burden of Disease Study 2019 (GBD 2019) includes health statistics from more than 200 countries, and researchers iterate on the latest data and research techniques, with estimates updated throughout the time series [ 11 ]. It is currently the most comprehensive and systematic database on the burden of disease globally and has been widely adopted for disease burden studies [ 12 ]. Based on the most recent GBD 2019 estimates, we systematically described the long-term trends in the burden of IBD among children and adolescents at global, regional, and national levels between 1990 and 2019, including prevalence and incidence.…”

Section: Introductionmentioning

confidence: 99%

Changing epidemiology of inflammatory bowel disease in children and adolescents

Long,

Wang,

Huang

et al. 2024

Int J Colorectal Dis

Self Cite

View full text Add to dashboard Cite

Background The incidence of inflammatory bowel disease (IBD) is rising worldwide, but epidemiological data on children and adolescents are lacking. Understanding the global burden of IBD among children and adolescents is essential for global standardization of methodology and treatment options. Methods This is a cross-sectional study based on aggregated data. We estimated the prevalence and incidence of IBD in children and adolescents between 1990 and 2019 according to the Global Burden of Disease Study 2019 (GBD 2019). Age-standardized rates (ASRs) and estimated annual percentage changes (EAPCs) were used to compare the burden and trends between different regions and countries. Results In 2019, there were 25,659 new cases and 88,829 prevalent cases of IBD among children and adolescents globally, representing an increase of 22.8% and 18.5%, respectively, compared to 1990. Over the past 30 years, the incidence and prevalence of IBD among children and adolescents have been highest in high SDI regions, with the most significant increases in East Asia and high-income Asia Pacific. At the age level, incidence and prevalence were significantly higher in the 15–19-year-old age group, while the < 5-year-old group showed the most significant increase in incidence and prevalence. Conclusion The incidence of IBD in children and adolescents is significantly on the rise in some countries and regions, and IBD will remain an important public health issue with extensive healthcare and economic costs in the future. The reported IBD burden in children and adolescents at the global, regional, and national levels will assist in the development of more precise health policies.

show abstract

Section: Introductionmentioning

confidence: 99%

Changing epidemiology of inflammatory bowel disease in children and adolescents

Long,

Wang,

Huang

et al. 2024

Int J Colorectal Dis

Self Cite

View full text Add to dashboard Cite

show abstract

“…It provides a comprehensive assessment of health losses globally between 1990 and 2019 for 204 countries and territories, 369 diseases and injuries, and 87 risk factors ( 13 , 14 ). It is currently the most extensive and credible database on the burden of disease worldwide and has been widely used in disease burden studies ( 14 , 15 ). Therefore, in this study, data on the burden of childhood ID, derived from the GBD database, are comprehensive and reliable.…”

Section: Introductionmentioning

confidence: 99%

Evolving trends and burden of iron deficiency among children, 1990–2019: a systematic analysis for the global burden of disease study 2019

Long,

Mao,

Liu

et al. 2023

Front. Nutr.

Self Cite

View full text Add to dashboard Cite

ObjectivesWe aimed to provide a timely, comprehensive, and reliable assessment of the burden of iron deficiency (ID) in children between 1990 and 2019 at the global, regional, and national levels to inform policymakers in developing locally appropriate health policies.MethodsData related to ID among children younger than 15 years old were analyzed by sex, age, year, socio-demographic index (SDI), and location according to the Global Burden of Disease Study 2019 (GBD 2019). Age-standardized rates were used to compare the burden between different regions and countries. Furthermore, the Joinpoint regression model was used to assess temporal trends from 1990 to 2019.ResultsIn 2019, the number of prevalent cases and disability-adjusted life years (DALYs) for ID in children were 391,491,699 and 13,620,231, respectively. The global age-standardized prevalence and DALY rates for childhood ID in 2019 were 20,146.35 (95% confidence interval: 19,407.85 to 20,888.54) and 698.90 (466.54 to 1015.31) per 100,000, respectively. Over the past 30 years, the global prevalence of ID among children has been highest in low-SDI regions, particularly in Western Sub-Saharan Africa, South Asia, and Eastern Sub-Saharan Africa. Since 1990, the prevalence and DALY of ID in children have been declining in most geographic regions. Nationally, Ecuador, China, and Chile have shown the most significant decreases in prevalence. The greatest decline in age-standardized DALY rate was observed in Ecuador, while Burkina Faso experienced the highest increase. Bhutan had the highest prevalence and DALY rates in 2019. On the age level, the prevalence was relatively higher among the <5 years age group. At the gender dimension, the prevalence of ID in children overall was more pronounced in girls than in boys, as was the case for DALY.ConclusionAlthough the burden of ID in children has been declining, this disease remains a major public health problem, especially in countries with low SDI. Children younger than 5 years of age are an important group for whom targeted measures are needed to reduce the burden of ID.

show abstract